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Abstract. – OBJECTIVE: Post-mastectomy
radiotherapy (PMRT) is well known in the plas-
tic surgery community for having a negative im-
pact on expander-implant based immediate
breast reconstruction (IBBR), although recently
some technical improvements allow better re-
sults. Very recent papers would suggest that
there is no difference in postoperative compli-
cations in patients receiving post-mastectomy
radiotherapy using modern techniques. Howev-
er, study results are often biased by small
groups of patients and by heterogeneity of ra-
diotherapy timing, different surgical techniques
and measured outcomes.
MATERIALS AND METHODS: We have con-
ducted a MEDLINE search to summarize the lat-
est data (2012-2014) on the topic. Search was
conducted using the following parameters:
breast reconstruction AND implant AND ex-
pander AND post-mastectomy radiotherapy.
RESULTS: The MEDLINE search showed 53
reports, demonstrating a great interest on this
topic; among these 37 dealed specifically with
post-mastectomy radiotherapy after breast re-
construction. In particular, 15 were amenable to
plastic surgeons, 6 to breast surgeons, 9 to ra-
diotherapists and 7 to oncologists. Papers
amenable to plastic surgeons highlighted the
highest rate of undesired results, although with
recent advances such as delayed-immediate re-
construction or protective lipofilling.
CONCLUSIONS: PMRT remains an undesired
event when pursuing an implant-based breast
reconstruction, although it does not represent
an absolute contraindication. The higher rate of
complications reported by plastic surgeons
and not by other specialists can be explained
with the greater attention to aesthetic details,
such as capsular contractures, that our com-
munity has. Technical strategies to prevent
complications described in this community
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now allow better results, should be well known
and improved if possible in the future.
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Introduction
Breast reconstruction is becoming more and
more an integral part of breast cancer treatment,
due to the younger age of detection and to the
good results now possible1,2. Expander/implant
based breast reconstruction appears to be the
most common type of breast reconstruction,
reaching 80% of any reconstruction in most cen-
ters3. The trend is moving undoubtly to immedi-
ate instead of delayed reconstruction4. On the
other side, trend towards partial and conservative
(Skin and Nipple Sparing Mastectomies, SSM &
NSM) mastectomies is creating a rise in the num-
ber of patients undergoing radiotherapy.
PMRT is currently indicated for patients with
T3 or stage III tumors and those with 4 or greater
positive axillary nodes. The median dose used in
patients with a tumor larger than 5 cm and with
more than 4 positive lymph nodes is 50 Gy five
days a week for 5 weeks5, although the indica-
tions are now broadening with lower doses (hy-
pofractionated therapy). PMRT is well known in
the medical community for having a negative im-
pact on immediate IBBR6, although new techni-
cal strategies are now decreasing complications.
However, in the last years several papers from
other scientific communities seem to invalidate
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these data, suggesting the feasibility of IBBR in
the setting of PMRT.
The aim of our study was the to review the
most recent data on this topic in order to have re-
alistic and updated results, elucidating modern
strategies to minimize complications.
Materials and Methods
The Pubmed search was set for the following
terms: breast reconstruction AND implant AND
expander AND post-mastectomy radiotherapy,
limitating the search to the period 2012-2014. All
studies that reported outcomes of expander/im-
plants reconstruction with the use of post-mas-
tectomy radiotherapy were searched. Relevant
publications were identified. Studies where data
could not be extracted or where patients number
was not relevant were excluded from the study.
Then, papers were also divided according to the
leading specialty analyzing data (e.g.: plastic
surgery, radiotherapy, oncology, etc.).
Results
Among papers published on the topic, most
were amenable to plastic surgeons, followed by,
in descending order, radiotherapists and radiolo-
gists, oncologists and breast surgeons. A summa-
rizing table follows (Table I).
Discussion
Breast cancer is the leading cause of death in
women worldwide with an estimated incidence of
1 every 9 woman affected. Surgery, combined
with radiotherapy and systemic oncological treat-
ments, represents the mainstay for stages II-III.
Breast conserving surgery and mastectomy are
the available surgical options: the choice between
them depends on tumor characteristics and patient
preferences1. Mastectomy followed by IBBR is,
in most cases, a favorable option2,4, however post-
reconstruction radiation therapy increases many
immediate and late complications (Figures 1 and
2) such as capsular contracture, tissue ulceration,
implant exposure with final implant removal and
reconstructive failure5,6. Patients who had PMRT
following immediate breast reconstruction with
autologous tissues demonstrated suboptimal aes-
thetic results with other kind of complications
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Specialty No of papers
Plastic Surgery 15
Radiotherapy 9
Oncology 7
Breast Surgery 6
Table I. Papers published on the topic divided according to
the leading specialty.
(liponecrosis, flap atrophy), which analysis is be-
yond the aim of this paper7.
Recently, the scenario has changed, together
with a great scientific interest on the topic. Al-
though PMRT has been considered a relative
contraindication to IBBR4, some studies are now
invalidating this consideration. On the other side,
new approaches such as the delayed-immediate
reconstruction8, the MSKCC protocol9 and pro-
tective lipofilling10 on irradiated expanders are
decreasing complications in this subset of pa-
tients.
Historically, the approach of radiologists and
radiotherapists was negative towards the effect of
irradiation to breast reconstruction, often sug-
gesting to delay reconstructive procedures.
Krueger compared the rates of complications and
patient satisfaction among breast cancer patients
treated with mastectomy and tissue expander/im-
plant reconstruction with and without radiothera-
py, showing how irradiated patients had a higher
rate of expander/implant reconstruction failure
and complications than non-irradiated patients5.
A study conducted in 2006 quantified the impact
of PMRT planning on immediate breast recon-
struction; patients who had mastectomy and im-
mediate reconstruction followed by radiation
therapy were compared with patients who had
undergone mastectomy without intervening re-
construction. The study showed that radiation
treatment planning after immediate breast recon-
struction was compromised in more than half of
the patients, with the largest compromises ob-
served in those with left-sided cancers6.
However, recently Anderson et al11 underlines
the feasibility of breast reconstruction in the set-
ting of PMRT with no significant difference in
the overall rate of major or minor complications
found between patients who underwent breast re-
construction with a tissue expander/implant or
permanent implant followed by PMRT.
Carnevale et al12 evaluated treatment related
complications, outcomes and patient satisfaction
2204
D. Ribuffo, A. Monfrecola, M. Guerra, G.M. Di Benedetto, L. Grassetti, E. Spaziani, T. Vitagliano, M. Greco
Figure 1. Chronic ulcerative radiodermatitis in a patient
who underwent breast reconstruction with prosthesis.
Figure 2. Salvage with Latissimus dorsi flap.
struction were far more likely to have a failure of
their reconstruction when compared to autolo-
gous reconstruction. Thirdly, the use of acellular
dermal matrices during reconstruction showed an
increased risk of major complications. Fourthly,
implant-based reconstruction also correlates with
higher rates of complications. Fifthly, factors like
age, BMI, smoking and diabetes were not associ-
ated with increased complications or reconstruc-
tion failure rates. Kronowitz15 in 2012 also high-
lights the increased complications of implant
based reconstruction in the setting of PMRT. He
identified 285 articles, 19 were reviewed in de-
tail. The most recent studies find a significant
need for unplanned or major corrective surgery in
irradiated breast reconstructed with implants. Pa-
tient surveys show that irradiation has a signifi-
cantly negative effect on patient satisfaction.
Particular types of mastectomy were also stud-
ied. Reish et al16 evaluated the breast reconstruc-
tion outcomes after nipple-sparing mastectomy
and radiation therapy. Outcomes of irradiated pa-
tients and non-irradiated patients were compared:
patients with radiation had higher incidence of a
secondary procedure for capsular contracture.
The total nipple retention rate in patients with ra-
diation and nipple-sparing mastectomy was high,
and the reconstruction failure rate was 8%. So
nipple-sparing mastectomy and immediate recon-
struction in patients who had or will have radia-
in women with locally advanced breast cancer
who received post-mastectomy radiation therapy
after breast reconstruction. Their conclusion was
that radiotherapy can be safely delivered after
breast reconstruction, with a low complication
rate and good patient satisfaction. Eriksson et al13
analyzed the effects of prior and postoperative ra-
diotherapy on surgical outcomes and patient-re-
ported outcome measures in implant based im-
mediate breast reconstruction. The post-operative
infection rate did not differ between postopera-
tively irradiated and non-irradiated patients but
was higher in previously irradiated patients.
The plastic surgery community usually high-
lights the complications caused by radiotherapy
in IBBR. Pestana et al14 tried to evaluate factors
associated with increased rate of complications
in women who underwent breast reconstruction
as well as radiotherapy. They conducted a review
of patients who underwent mastectomy, radiation
and breast reconstruction, and collected patient
demographics, operative procedure, breast irradi-
ation timing and postoperative complications.
Firstly, they found that the timing of the radiation
can be a significant factor that can affect out-
comes in irradiated breast reconstructions: pa-
tients who underwent irradiation before recon-
struction were much better than patients who had
radiotherapy after reconstruction to be complet-
ed. Secondly, patients with implant-based recon-
tion is associated with higher incidence of com-
plications and operative revisions compared to
patients without radiation.
In the effort of limitating complications, a
question was raised on the possible benefit of ir-
radiating deflated expanders. A study conducted
by Celet Ozden17 on rabbits answered to this
question, showing that expander deflation imme-
diately prior to radiotherapy may even increase
the adverse effects such as chronic radiodermati-
tis (epidermal atrophy, dermal inflammation and
fibrosis, neovascularisation and vascular changes
as well as increased capsule thickness) especially
around the lower expander pole. Newer tech-
niques such as protective lipofilling or the de-
layed-immediate approach are helping. Protec-
tive lipofilling aims at giving at irradiated ex-
panders a fat capsule, thus, avoiding skin ulcera-
tion, capsular contracture, and implant exposure.
The delayed-approach, described by Kro-
nowitz9, bypasses the problem but indeed propos-
es the use of autologous tissue, after radiotherapy
on the expander. In summary, the point of view
of plastic surgeons on the problem remains skep-
tical18,19.
Recently, Cordeiro et al20 published the largest
prospective long-term study concerning the out-
comes evaluation in women with immediate tis-
sue expander/implant reconstruction and post-
mastectomy radiation therapy. The study was
conducted on a total of 2133 breast implant re-
constructions with a mean follow-up of 56.8
months. Three hundred nineteen implants re-
ceived radiation. Implant loss occurred in 9.1%
of irradiated implants and 0.5 percent of nonirra-
diated implants. Capsular contracture grade IV
was present in 6.9 percent of irradiated and 0.5
percent of nonirradiated implants. Theey found
no difference between groups regarding implant
replacement. Ninety-two percent of irradiated pa-
tients had good to excellent aesthetic result, and
94.2% would choose implants again. Predicted
implant loss rates were 17.5% and 2.0% for irra-
diated and nonirradiated implants, respectively,
at 12 years, and predicted implant replacement
rates were 12.7 percent and 8.8 percent, respec-
tively, at 8 years. Most patients had a good to ex-
cellent aesthetic result and preserve their recon-
struction at 12 years20.
The opinion of general surgeons (breast sur-
geons) is someway in the middle. Korwar et al21
illustrated the effects of radiotherapy on compli-
cations and patient reported outcomes after skin
reducing mastectomy and immediate reconstruc-
tion. A prospective database of women undergo-
ing skin reducing mastectomy, dermal sling and
immediate implant reconstruction was analyzed.
They found no statistically significant increased
rate of major complications like implant loss and
capsular contracture when skin reducing mastec-
tomy and immediate reconstruction are com-
bined with radiotherapy. In their opinion, the
overall patient satisfaction was high even after
radiotherapy.
Baschnagel et al22 reported the rate of breast
reconstruction failure and cosmetic outcomes af-
ter post-mastectomy radiation therapy with tem-
porary tissue expanders or implants in place. No
risk factors, as smoking, diabetes mellitus, hyper-
tension, menopausal status, were found to be as-
sociated with reconstruction failure. In many pa-
tients who did not experience reconstruction fail-
ure, good cosmesis was observed.
Shah et al23 examined cosmesis, complica-
tions, and factors associated with aesthetic out-
comes in patients undergoing reconstruction and
receiving post-mastectomy radiotherapy: radio-
therapy with breast reconstruction is potentially
associated with increased rates of complications
and reconstruction loss regardless of reconstruc-
tion techniques utilized.
Sharpe et al24 studied the impact of bilateral
mastectomy versus unilateral mastectomy on
short term outcomes and adjuvant therapy: bilat-
eral mastectomy patients have significantly
greater delays in having surgery and receiving
adjuvant therapy; however, these data may not be
clinically significant.
Collier et al25 studied the problem minimizing
the deleterious effect of radiotherapy following
54 patients who underwent implant based breast
reconstruction and received postmastectomy ra-
diation and comparing complications such as in-
fection, implant loss and capsular contracture be-
tween two groups. What they observed was that
the timing of radiation did not affect individual
complication rates for patient who underwent im-
plant-based breast reconstruction after immediate
tissue expander placement. The same conclusion
was reached by Aristei et al26, they in particular
followed 101 patients, from 1997 to 2009, who
received RT after breast reconstruction. 92 of
these, because of risk factors for relapse and 9
because the relapse had occurred. At RT, 90 pa-
tients had temporary tissue expanders and 11 had
permanent implants. 12 patients underwent neo-
adjuvant chemotherapy; all patients received ad-
juvant chemo-and/or hormone therapy. What he
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observed was that at a median follow-up of 50
months, late toxicities occurred in 28 patients
such as pain, lymphedema, cutaneous and subcu-
taneous toxicity, rupture, displacement or loss of
shape of the prosthesis was observed in 8 pa-
tients. Capsular contracture of various stage was
classified in 89 patients. A total of 12 prosthesis
were removed. Judgments of cosmetic results
were available from 81 physicians and 84 pa-
tients. Outcomes were excellent/good in 58-81
physician judgments and in 57/84 patient evalua-
tions. Overall inter-rater agreement on outcome
was good.
In conclusion, he asserts that RT to recon-
structed breast was associated with low rates of
late toxicity and prosthesis removal as well as
cosmetic outcomes that were, on the whole, good
to excellent.
Conclusions
The use of PMRT is increasing, together with
the trend towards breast conserving surgery, and
this can increase the rate of complications in pa-
tients undergoing breast reconstruction, espe-
cially for IBBR. The positive results reported in
some studies are amenable to different special-
ties other than Plastic Surgery, and can be con-
fusing. PMRT remains an undesired event in the
setting of immediate breast reconstruction, par-
ticularly when performed with expander and
implants27-32. However, PMRT should NOT be
considered anymore a contraindication to ex-
pander-implant based breast reconstruction33-35,
because of new techniques and protocols such
as 1) the delayed immediate approach 2) the
MSKCC protocol and 3) protective lipofilling on
irradiated expanders36,37.
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